Fairmount Funds Management as of March 31, 2021
Portfolio Holdings for Fairmount Funds Management
Fairmount Funds Management holds 21 positions in its portfolio as reported in the March 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Insmed Com Par $.01 (INSM) | 13.8 | $33M | 962k | 34.06 | |
| Zogenix Com New | 11.6 | $27M | 1.4M | 19.52 | |
| Iovance Biotherapeutics (IOVA) | 7.6 | $18M | 566k | 31.66 | |
| Allakos (ALLK) | 7.1 | $17M | 148k | 114.78 | |
| Axsome Therapeutics (AXSM) | 6.0 | $14M | 252k | 56.62 | |
| Trillium Therapeutics Com New | 6.0 | $14M | 1.3M | 10.74 | |
| Argenx Se Sponsored Adr (ARGX) | 6.0 | $14M | 52k | 275.39 | |
| Instil Bio | 5.8 | $14M | 550k | 25.08 | |
| Cogent Biosciences (COGT) | 5.8 | $14M | 1.6M | 8.78 | |
| Mirati Therapeutics | 4.9 | $12M | 68k | 171.30 | |
| ACADIA Pharmaceuticals (ACAD) | 4.7 | $11M | 432k | 25.80 | |
| Amarin Corp Spons Adr New (AMRN) | 4.2 | $10M | 1.6M | 6.21 | |
| Enanta Pharmaceuticals (ENTA) | 3.6 | $8.4M | 171k | 49.32 | |
| Amicus Therapeutics (FOLD) | 3.3 | $7.8M | 789k | 9.88 | |
| Seres Therapeutics (MCRB) | 3.1 | $7.3M | 353k | 20.59 | |
| Global Blood Therapeutics In | 3.0 | $7.1M | 175k | 40.75 | |
| Keros Therapeutics (KROS) | 2.8 | $6.7M | 109k | 61.55 | |
| Verona Pharma Sponsored Ads (VRNA) | 0.3 | $702k | 84k | 8.36 | |
| Miragen Therapeutics (VRDN) | 0.2 | $581k | 35k | 16.56 | |
| Therapeutics Acquisition Cor Com Cl A | 0.2 | $526k | 50k | 10.52 | |
| Catabasis Pharmaceuticals In Com New | 0.1 | $154k | 53k | 2.90 |
